Insider Trading & Ownership of STEVEN M. PAUL

Location: Boston, MA
Summary: The estimated net worth of STEVEN M. PAUL is at least $1,225,770 dollars as of 15 Sep 2025. STEVEN M. PAUL is the Director of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $1.04M. STEVEN M. PAUL is the Director of ALNYLAM PHARMACEUTICALS, INC. and owns shares of ALNYLAM PHARMACEUTICALS, INC. (ALNY) stock worth about $185.3K.
Signature: /s/ Troy Ignelzi, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when STEVEN M. PAUL files a new Insider Trading report.

Ownership of STEVEN M. PAUL

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
RAPP	Rapport Therapeutics, Inc.	Director	$1,040,450	+$1,027,111	+7700%	12 Sep 2025
ALNY	ALNYLAM PHARMACEUTICALS, INC.	Director	$185,320			01 Apr 2022
KRTX	Karuna Therapeutics, Inc.	Director	$0			18 Mar 2024
SAGE	Sage Therapeutics, Inc.	Director				03 Jan 2024
VYGR	Voyager Therapeutics, Inc.	Director				03 Jun 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.